BaxBEWozneyJMAshhurstDE. Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif Tissue Int.1999;65:83–9.
2.
BostromMLaneJMTominE. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop.1996;327:272–82.
3.
BouxseinMLTurekTJBlakeCA. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg.2001;83:1219–30.
4.
BoynePJ. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg.2001;83:146–50.
5.
BoynePJLillyLCMarxRE. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg.2005;63:1693–707.
6.
BoynePJMarxRENevinsM. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent.1997;17(1):11–25.
7.
BurkusJKSandhuHSGornetMF. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg.2005;87(6):1205–12.
8.
CookSDSalkeldSLBrinkerMR. Use of an osteoinductive biomaterial (RhOP-1) in healing large segmental bone defects. J Orthop Trauma.1998;12:407–12.
9.
DeCosterTAGehlertRJMikolaEA. Management of posttraumatic segmental bone defects. JAAOS.2004;12:28–38.
10.
EdwardsRB3rdSeehermanHJBogdanskeJJ. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J Bone Joint Surg.2004;86:1425–38.
11.
GlassmanSDCarreonLDjurasovicM. Posterolateral lumbar spine fusion with INFUSE bone graft. Spine.2007;J 7 (1):44–9. PMID: 17197332.
12.
GovenderSCsimmaCGenantHK. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. J Bone Joint Surg.2002;84-A:2123–34. PMID: 12473698.
13.
HaidRWJrBranchCLJrAlexanderJT. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine.2004;J 4 (5):527–38. PMID: 15363423.
14.
JohnsonEEUristMR. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop.2000;371:61–74.
15.
JonesALBucholzRWBosseMJ. A Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects: a randomized, controlled trial. J Bone Joint Surg.2006;88(7):1431–41.
16.
McKayBSandhuHS. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine.2002;27:S66–85.
17.
MoroniARolloGGuzzardellaM. Surgical treatment of isolated forearm non-union with segmental bone loss. Injury.1997;28(8):497–504.
18.
NauthARistiniemiJMcKeeMD. Bone morphogenetic proteins in open fractures: past, present, and future. Injury.2009;40 Suppl 3:S27–31.
19.
ReddiAH. Initiation of fracture repair by bone morphogenetic proteins. Clin Orthop Relat Res.1998;355S:s66–72.
20.
RiewKDWrightNMChengS. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int.1998;63:357–60.
21.
RingDAllendeCJafarniaK. Ununited diaphyseal forearm fractures with segmental defects: plate fixation and autogenous cancellous bone-grafting. J Bone Joint Surg.2004;86:2440–5.
22.
SchwartzNDHicksBM. Eight-centimeter segmental ulnar defect treated with recombinant human bone orphogenetic protein-2. Am J Orthop (Belle Mead NJ).2008;37(11):569–71.
23.
SciadiniMFJohnsonKD. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model. J Orthop Res.2000;18(2):289–302.
24.
SwiontkowskiMFAroHTDonellS. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg.2006;88(6):1258–65.
25.
UristMRSilvermanBFBuringK. The bone induction principle. Clin Orthop Relat Res.1967;53:243–83.
26.
Valentin-OpranAWozneyJCsimmaC. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop.2002;395:110–20.
